MarketDataForecast.com - According to the recent survey, “Lung Cancer Therapeutics” the total market is expected to reach $7.81 billion by 2021 at an estimated CAGR of 6.7% from 2016 to 2021.

1. RESEARCH REPORT
MAR 2017
GLOBAL LUNG CANCER THERAPEUTICS MARKET
SEGMENTED BY TYPE AND REGION, INDUSTRY ANALYSIS, SIZE,
SHARE, GROWTH TRENDS AND FORECASTS 2016-2021

2. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
According to the report "Lung Cancer Therapeutics Market", published by Market Data
Forecast, the global market is projected to reach USD 7.81 Billion by 2021, at a CAGR of 6.7%
from 2016 to 2021.
Lung cancer is a malignant lung carcinoma which is characterized by irregular cell growth in
lung tissue. As the tumour grows in size, it reduces the lungs’ ability to provide oxygen to
arteries, veins and capillaries. It is the common cause of mortality and illness not only in
developed countries but also in developing countries. Smoking is thought as a main cause of
lung cancer, though lung cancer also follows in non-smokers.
Air pollution, amplified alcohol consumption, varying life style, smoking, unhealthy food, and
no physical activity are the factors indirectly driving the market. Governments in the
developing economies are providing awareness among the people about the cancer. As the
geriatric population is likely to increase, the incidence of lung cancer is predicted to rise, thus
acting as a driver for revenue growth.
Global Market for Lung Cancer Therapeutics is segmented based on Type of Treatment
and Region into further sub-segments as follows:
1. By Treatment Type:
 Chemotherapy
 Cisplatin
 Taxol
 Navelbine
 Camptosar
 Alimta
 Radiotherapy
 External Beam
 Internal Beam
 Systemic
 Drugs Type
 Abraxane
 Avastin
 Crizotinib
 Docetaxel
 Gefitinib
2. By Geography:
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle-East and Africa

3. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
The prominent players of this market include BoehringerIngelheim GmbH, Hoffman-La Roche,
Pfizer Inc., GlaxoSmitKline, Eli Lilly and Company, Agennix AG, AstrazenecaPlc and Sanofi-
Aventis.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
View Report at http://www.marketdataforecast.com/market-reports/global-lung-cancer-
therapeutics-market-893/
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Treatment Type
Get free sample report at http://www.marketdataforecast.com/market-reports/global-
lung-cancer-therapeutics-market-893/request-sample
5.1.1 Chemotherapy
5.1.1.1 Cisplatin
5.1.1.2 Taxol
5.1.1.3 Navelbine
5.1.1.4 Camptosar
5.1.1.5 Alimta
5.1.2 Radiotherapy
5.1.2.1 External Beam
5.1.2.2 Internal Beam
5.1.2.3 Systemic
5.1.3 Other Drugs
5.1.3.1 Abraxane
5.1.3.2 Avastin

5. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
5.1.3.3 Crizotinib
5.1.3.4 Docetaxel
5.1.3.5 Gefitinib
6. Geographical Analysis
Request Customization at http://www.marketdataforecast.com/market-reports/global-
lung-cancer-therapeutics-market-893/customize-report
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-
lung-cancer-therapeutics-market-893/inquire
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India

6. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
6.3.4 Japan
6.3.5 South Korea
6.3.6 Australia
6.4 Latin America
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-lung-
cancer-therapeutics-market-893
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Mexico
6.4.4 Argentina
6.4.5 Rest of Latin America
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Pipeline Product Analysis
7.1 Overview
7.2 Pipeline Development Landscape
7.3 Molecular Targets in the Pipeline
7.4 Clinical Trials
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type
and Molecular Target

7. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
7.4.2 Clinical Trial Duration by Stage of Development, Indication,
Molecule Type and Molecular Target
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule
Type and Molecular Target.
8. Strategic Analysis
8.1 PESTLE analysis
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Legal
8.1.6 Environmental
8.2 Porter’s Five analysis
8.2.1 Bargaining Power of Suppliers
8.2.2 Bargaining Power of Consumers
8.2.3 Threat of New Entrants
8.2.4 Threat of Substitute Products and Services
8.2.5 Competitive Rivalry within the Industry
9. Market Leaders' Analysis
9.1 BoehringerIngelheim GmbH
9.1.1 Overview
9.1.2 Product Analysis
9.1.3 Strategic Evaluation and Operations

8. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
9.1.4 Financial analysis
9.1.5 Legal issues
9.1.6 Recent Developments
9.1.7 SWOT analysis
9.1.8 Analyst View
9.2 Hoffman-La Roche
9.3 Pfizer Inc.
9.4 GlaxoSmitKline
9.5 Eli Lilly and Company
9.6 AstrazenecaPlc
9.7 Sanofi-Aventis
9.8 Agennix AG
10. Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11. Expert Opinions
11.1 Market Outlook
11.2 Investment Opportunities
Appendix
a) List of Tables

9. Global Lung Cancer Therapeutics Market
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
b) List of Figures
For more related reports from Therapeutics segment:
 Cervical Cancer Diagnostics and Therapeutics Market:
http://www.marketdataforecast.com/market-reports/global-cervical-cancer-
diagnostics-and-therapeutics-market-829/
 Colorectal Cancer Market: http://www.marketdataforecast.com/market-
reports/global-colorectal-cancer-market-612/
SCOPE OF THE REPORT
 Global, regional and country-level analysis and forecasts of the study market;
providing Insights on the major countries/regions in which this industry is blooming
and to also identify the regions that are still untapped
 Segment-level analysis in terms of technology, component, and type along with
market size forecasts and estimations to detect key areas of industry growth in detail
 Identification of key drivers, restraints, opportunities, and challenges (DROC) in the
market and their impact on shifting market dynamics
 Study of the effect of exogenous and endogenous factors that affect the global
market; which includes broadly demographic, economics, and political, among other
macro-environmental factors presented in an extensive PESTLE Analysis
 Study the micro environment factors that determine the overall profitability of an
Industry, using Porter’s five forces analysis for analyzing the level of competition and
business strategy development
 A comprehensive list of key market players along with their product portfolio, current
strategic interests, key financial information, legal issues, SWOT analysis and analyst
overview to study and sustain the market environment
 Expertly devised analyst overview along with Investment opportunities to provide
both individuals and organizations a strong financial foothold in the market

10. +1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
ABOUT US
Market Data Forecast is a firm working in the areas of market research
and business intelligence. We have rich experience in research across
various business domains and we cater to the needs of both individual
and corporate clients. Our research services assist clients in key
business areas like business process improvement, key decision
making and developing appropriate corporate strategy. We are truly
committed to our clients and other stakeholders for providing
customized research services of the highest quality.
CONTACT INFORMATION
We always look forward to working with new clients, pushing our
boundaries and extending our reach beyond global horizons. Get in
touch with us for further queries.
Website: www.marketdataforecast.com
E-Mail: contact@marketdataforecast.com
Phone: +1 888-702-9626 (U.S Toll free),
+91 7680952236 (Indian Office).
FOR MORE INFORMATION